Australian trial shows bivalent mRNA COVID-19 booster lifts antibodies more than protein vaccine, yet both cut infection similarly over 12 months.
Paul V. Licciardi, BSc(Hons), PhD
Advertisement
Articles by Paul V. Licciardi, BSc(Hons), PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
Fall 2026 Quiz: Test Your Pharmacy Knowledge!
4
Oncology Pharmacists Reduce Adverse Drug Reactions in Hematologic Cancer Care
5